HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/1/L249    most recent 00088.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by McDevitt, T. M. Articles by Ballard, P. L. Search for Related Content PubMed PubMed Citation Articles by McDevitt, T. M. Articles by Ballard, P. L.

Role of endogenous TGF- in glucocorticoid-induced lung type II cell differentiation

Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Submitted 9 March 2006 ; accepted in final form 19 September 2006

In the fetal lung, endogenous transforming growth factor (TGF)- inhibits early morphogenesis and blocks hormone-induced type II cell differentiation. We hypothesized that endogenous TGF- inhibits type II cell differentiation and that the stimulatory effects of glucocorticoids result in part from suppression of TGF-. Epithelial cells were isolated from human fetal lung and cultured under defined conditions with and without dexamethasone plus cAMP to promote type II cell differentiation. Control cells produced TGF-, which was activated in part by _V6-integrin. Treatment with dexamethasone, but not cAMP, reduced TGF-1 and -2 transcripts and TGF- bioactivity in culture medium. To examine the effects of decreased TGF- in the absence of glucocorticoid, cells were treated with antibodies to TGF- and its receptors. By real-time RT-PCR, antibody blockade of TGF- reduced serpine1, a TGF--inducible gene, and increased gene expression for sftpa, sftpb, sftpc, and titf1, mimicking the response to hormone treatment. By microarray analysis, 29 additional genes were induced by both TGF- antibody and hormone treatment, and 20 other genes were repressed by both treatments. For some genes, the fold response was comparable for antibody and hormone treatment. We conclude that endogenous TGF- suppresses expression of surfactant proteins and selected other type II cell genes in fetal lung, in part secondary to increased expression of titf1, and we propose that the mechanism of glucocorticoid-induced type II cell differentiation includes antagonism of TGF- gene suppression. Surfactant production during fetal development is likely influenced by relative levels of TGF- and glucocorticoids.

surfactant protein; thyroid transcription factor-1; dexamethasone; integrin; gene expression

This article has been cited by other articles:

				T. Harayama, H. Shindou, and T. Shimizu Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1 J. Lipid Res., September 1, 2009; 50(9): 1824 - 1831. [Abstract] [Full Text] [PDF]

				V. Kolla, L. W. Gonzales, N. A. Bailey, P. Wang, S. Angampalli, M. H. Godinez, M. Madesh, and P. L. Ballard Carcinoembryonic cell adhesion molecule 6 in human lung: regulated expression of a multifunctional type II cell protein Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L1019 - L1030. [Abstract] [Full Text] [PDF]

				A. K. Lovgren, M. Kovarova, and B. H. Koller cPGES/p23 Is Required for Glucocorticoid Receptor Function and Embryonic Growth but Not Prostaglandin E2 Synthesis Mol. Cell. Biol., June 15, 2007; 27(12): 4416 - 4430. [Abstract] [Full Text] [PDF]